A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers

BACKGROUND: The genetic variation underlying atorvastatin (ATV) pharmacokinetics was evaluated in a Mexican population. Aims of this study were: 1) to reveal the frequency of 87 polymorphisms in 36 genes related to drug metabolism in healthy Mexican volunteers, 2) to evaluate the impact of these pol...

Descripción completa

Detalles Bibliográficos
Autores principales: León-Cachón, Rafael B. R., Ascacio-Martínez, Jorge A., Gamino-Peña, María E., Cerda-Flores, Ricardo M., Meester, Irene, Gallardo-Blanco, Hugo L., Gómez-Silva, Magdalena, Piñeyro-Garza, Everardo, Barrera-Saldaña, Hugo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746878/
https://www.ncbi.nlm.nih.gov/pubmed/26857559
http://dx.doi.org/10.1186/s12885-016-2062-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746878/
https://www.ncbi.nlm.nih.gov/pubmed/26857559
http://dx.doi.org/10.1186/s12885-016-2062-2

Ejemplares similares